GeekWire April 2, 2024
Charlotte Schubert

Researchers opened the doors Monday to the new Seattle Hub for Synthetic Biology, a collaboration between the Allen Institute, the Chan Zuckerberg Initiative and the University of Washington.

The hub combines “academic creativity with startup-style industrial execution,” said Jesse Gray, senior director of scientific operations and strategy, who was previously head of discovery at gene editing startup Ascidian Therapeutics.

The hub’s first main goal is to build a “biological recorder mouse,” enabling researchers to track biological actions such as cell divisions and molecular signaling in a live mouse across time.

Monday’s tour took place at the hub’s labs at Dexter Yard, a life sciences development in the South Lake Union neighborhood across from the Allen Institute, which is contributing $35...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Precision Medicine
Project Optimus: helping or hindering cancer drug development?
Faster Drug Discovery: Yseop & AWS Unveils GenAI Tool for Biopharma R&D
Quest to ramp up AI capabilities with purchase of PathAI’s diagnostic lab
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
mRNA Vaccines: Not Just for COVID Soon?

Share This Article